RecensMedical, Inc. (KOSDAQ:394420)

Market Cap	208.87B
Revenue (ttm)	7.60B +31.7%
Net Income	-17.38B
EPS	-2,148.78
Shares Out	10.85M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	186,144
Open	18,500
Previous Close	18,490
Day's Range	17,810 - 19,840
52-Week Range	17,550 - 39,900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 29, 2026

About RecensMedical

RecensMedical, Inc. operates as a medical device company specializing in precision cooling therapy and transdermal drug delivery solutions. The company engages in the development of precision medical cooling device in the fields of ophthalmology and dermatology. The company’s products include OcuCool, a hand-held, cooling anesthesia device that provides rapid and controlled cooling to the conjunctiva and sclera, and TargetCool, a handheld device that delivers rapid, precise, and controlled cooling to the skin tissue for the temporary reduction ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394420

Financial Performance

In 2025, RecensMedical's revenue was 8.83 billion, an increase of 41.05% compared to the previous year's 6.26 billion. Losses were -19.12 billion, 143.8% more than in 2024.